Tests performed study different parameters of vigilancy, and performances in real driving situation.
|
|
- Priscilla Hensley
- 6 years ago
- Views:
Transcription
1 DOUBLE-BLIND STUDY OF THE EFFECTS OF A COMBINATION OF BROMAZEPAM-ALCOHOL VS PLACEBO-ALCOHOL IN 11 AUTOMOBILE DRIVERS 1) C. MERCIER-GUYON, Centre Midico-Sportif, ANNECY, F. 2) F. RICHET, L.A.R.C.C.A., BRETIGNY/ORGE, F. 3) J. LEVEAU, PRODUITS ROCHE, PARIS, F. 4) M. GILBERT, ESSA, LYON, F. 5) L. CROCQ, Lab. de Psychopathologie, PARIS V, F. SUMMARY : The potential reciprocity between alcohol drinking and benzodiazepines is frequently evoked in traffic safety. The aim of this double-blind cross-over study on 11 healthy drivers is to know eventual related effects of oral bromazepam (6 mg/day) with alcohol drinking (0,5 g/1). The study is divided in 4 periods of 7 days (treatment or placebo) each separated to the next one by a 7 days wash-out. The tests are performed at the end of each period without or with alcohol drinking, just before. Tests performed study different parameters of vigilancy, and performances in real driving situation. For such a design the results show no significant differences between placebo-alcohol group and bromazepam-alcohol group. The reciprocal potentialization associated with simultaneous intake of alcohol and Benzodiazepines is a problem which is frequently raised in relation to road safety. This notion is primarily based on " a posteriori" studies of road accidents and in most cases an over intake of one or other of the products is observed. Without, in any way, putting into question the principle of a potentialization, frequently studied elsewhere, it seems of interest to us to study this problem from the standpoint of the general practitioner. Patients treated with anxiolytics sometimes ask if they can drink moderate amounts of alcohol. We concerned ourselves specifically with the combination of a non-sedative anxiolytic treatment, Bromazepam, and a mean alcoholemia level which, while legal in France, is illegal in other countries of the EEC. This level was fixed at between 0.4 and 0.5 g/1. Bromazepam is an anxiolytic benzodiazepine which bioavailability is 84 %. T max is about 1 h 30 and elimination half-life is 20 hours. Bromazepam has broadly an urinary elimination by the way of inactives metabolites. This double-blind placebo-controlled study with cross-over was carried out in 11 healthy male volunteers, aged between 18 and 32 years with no progressive disease and no other drug intake during the time of experimentation. The only 489
2 allowable intake of alcohol during the study was that required for the carrying out of test for each subject. Methods : Four test sessions took place : at D7 after 7 days of treatment with placebo or Bromazepam (study of product effect only) at D21 after 7 day wash out and 7 days of bromazepam or placebo (study of product effect only) at D35 after 7 day wash out and 7 days of treatment (placebo or Bromazepam) with a single intake of alcohol prior to test session at D49 After 7 day wash out and 7 days of treatment (Bromazepam or placebo) and a single intake of alcohol prior to test session. Two cross-overs were thus carried out :. between DO and D21. between D28 and D49 The two cross-overs were independent one from the other and the sequence placebo-active product was not necessarily the same for each subject. Alcoholemia measurements were taken at D35 and D49 using a breathalyser. Tests for the presence of Benzodiazepine in urine were carried out at D7, D21, D35 and D49. The experimental protocol was submitted to and approved by the institutional review board of Grenoble. Informed consent was obtained from subjects prior to the beginning of the study. Appendix 1 The test battery carried out at each session consisted of:. a self-appaisal questionnaire concerning - internal tension - level of anxiety - degree of drowsiness - psycho-retardation - physical retardation a test of diffused attention a study of emotional control of muscular tone (measurement of the polygon of support) a driving test carried out in real traffic conditions with a simultaneous study of visual reaction times to stimuli appearing in different places in the field of vision, as well as a study of reaction time to auditory stimuli. The analysis of results was carried out in 2 stages : 490
3 a curve was plotted for each test for each subject : on the abscissa, the chronological order of test taking, and on the ordinate the subject score, the higher the value the worse the score. This non-statistical method permitted a first approach to the effects of different treatments with the appearance of "troughs" corresponding to improvements, and peaks corresponding to deteriorations. This procedure, complementary to conventional statistical analysis, allows by a descriptive approach the detection of subjects who are particularly sensitive or resistant to the effects of treatment. The strictly statistical analysis consisted of : a one factor (time) analysis of variance ot the 4 test sessions by chronological order an analysis of the effect of alcohol alone, whether the subject received Bromazepam or not (Wilcoxon test) an analysis of the effect of the treatment product, whether the subject took alcohol or not (Wilcoxon test) separate analysis of the two cross-overs : order effect, treatment product effect (Wilcoxon test) Results On a statistical level, the study reveals no significant differences, for the different tests, between the placebo group and the Bromazepam group, when there is no association with alcohol. This study, correlated to other studies carried out with Bromazepam, confirms the absence of a sedative effect at usual therapeutic doses (6 mg/day) A previously recognized notion however appears : a sensation of drowsiness is observed in certain subjects, but it is not associated with a decrease in performance contrary to what has been observed \^ith an isolated intake of alcohol. Moreover, no significant difference has been found between the placeboalcohol group and the Bromazepam-alcohol group. These results thus allow it to be stated that the classical alteration of performance associated with alcohol intake and proportional to the amount ingested are in no way potentialized by a moderate therapeutic dose of Bromazepam. Comparison with the data in the literature however indicate that there is a summative effect, more than potentialization, when the dose of Bromazepam is higher than 12 mg/day and the alcoholemia level is greater than 0.8 g/1. Conclusion It is advisable to draw to the attention of patients treated with Bromazepam the danger of an alteration of performance and vigilance when the product is combined with alcohol. Above a certain threshold the two products together lead to an alteration of performance. 491
4 Nevertheless, it can be stated that with usual doses of Bromazepam the performance level is linked to alcoholemia and is not potentialized by the treatment. The alcoholemia must, of course, be as close to zero as possible in patients under treatment as well as in those not under treatment. BIBLIOGRAPHY 1. Antonelli, F. and al. Effects of a new sedative (Lexotan) on reaction time and attention capacity of a group of athletes. "3rd World Congress of the International Society of Sport Psychology". Madrid /06/ Brunaud, J.P. (1981). Essai d'estimation de la vigilance par signaux lumineux alatoires en situation monotone prolonge - application l'tude d'une benzodiazpine. Thse pour le Doctorat en mdecine, Universit Paris XII. 3. Chouraqui, J.(1968). Vigilance, psvchotropes et conduite automobile. Facult de decine et Pharmacie. Universit de Toulouse. 4. Clarke, C.H., Nicholson, A.N. (1978). Immediate and residual effect in man of the metabolites of diazepam. Br. J. Clin. Pharmacol.. 6, COLMARD P. (1989). Alcool et mdicaments psychotropes. Panorama du Mdecin. N Cowart, V., Kandela, P. (1985). Prescription Drugs and driving performance. JAMA.. 10, N 108, pp Crocq, L., Crocq, M.A. (1988). Informatique et Psychiatrie. E.M.C., Psychiatrie 37060, 10p. 8. Hindmarch, I., Parrott, A.C., Hickey, B.J., Clydec, A. (1980). An investigation into the effects of repeated doses of temazepam on aspects of sleep, early morning behaviour and psychomotor performance is norma subjects. Drugs Expti. Clin. Res.. 6, Hauert, G. (1986). Benzodiazepines and road accidents. Munich West Germany : Psychopharmaka im's rassenverkehr. Med. Welt Mattila, M.-J. (1984) Interaction of benzodiazepine on psychomotor skills. Brit. J. Clin. Pharmacology. 18, 21S-26S. 11. Mercier-Guyon, C., Eteradossi, J. (1987). Bromazpam: vigilance et performances. La Gazette Mdicale. 94. N Nicholson, A.N. (1982). Les anxiolytiques chez l'homme : tudes sur le sommeil et sur les capacits de rendement. L'Encphale. VIII Richalet, J.-P. (1981). Mesure du temps de raction complexe d'un pilote automobile 1'occasion d'une preuve d'endurance au niveau international. Mdecine du Sport. 55, N
5 14. Sario, I., Seppala, T. (1978). Dose response effects of bromazepam on psychomotor skills. Europ. J. Clin. Pharmacol.. 13, N6, Sario, I. et al. (1976). Effects of hypnotic and psychotropic drugs and alcohol on psvchomotor skills. Piss. Helsinki/Fin., pp ) Volkerts, E.-R. et al. (1986). Residual effect of lormetazepam and oxazepam on driving performance measured in an over the road driving test and a laboratory driving simulation test. loe International conference on alcohol drugs and traffic safety. Amsterdam. 17. Woods, J.-H. et al. (1989). Us et abus des benzodiazpines. JAMA. 14. n
MIDAZOLAM AND OXAZEPAM IN THE TREATMENT OF INSOMNIA IN HOSPITALIZED PATIENTS
Br. J. clin. Pharmac. (1983), 16, 145S-149S MIDAZOLAM AND OXAZEPAM IN THE TREATMENT OF INSOMNIA IN HOSPITALIZED PATIENTS 'Clinique des Maladies Infectieuses, H6pital Houphouet Boigny, Marseilles, France
More informationClinical Impairment of Benzodiazepines Relation between Benzodiazepine Concentrations and Impairment in Apprehended Drivers.
Clinical Impairment of Benzodiazepines Relation between Benzodiazepine Concentrations and Impairment in Apprehended Drivers. 1 J.G. Bramness, 2 S. Skurtveit, and 1 J. Mørland 1 National Institute of Forensic
More informationThe Effects of Clobazam Upon Critical Flicker Fusion Thresholds: A Review
Drug Development Research Supplement 157-66 (1982) The Effects of Clobazam Upon Critical Flicker Fusion Thresholds: A Review A.C. Parrott Department of Psychology, University of Leeds, Leeds, England ABSTRACT
More informationDriving tests with patients
Br. J. clin. Pharmac. (1984), 18, 103S-108S Driving tests with patients J. J. de GIER Department of Pharmacotherapy, Subfaculty of Pharmacy, Drugs and Driving Research Group, State University of Utrecht,
More informationHypnotics drugs residual effects on monotonous simulated driving in elderly drivers
Hypnotics drugs residual effects on monotonous simulated driving in elderly drivers ML Bocca 1-2, S Marie 2, C. Berthelon 3*, A. Coquerel 2, V. Lelong-Boulouard 2, M. Moessinger 4, P. Denise 2 1 : Paris
More informationCLINICAL INVESTIGATION OF MEDICAL PRODUCTS IN THE TREATMENT OF GENERALISED ANXIETY DISORDER, PANIC DISORDER AND OBSESSIVE- COMPULSIVE DISORDER
CLINICAL INVESTIGATION OF MEDICAL PRODUCTS IN THE TREATMENT OF GENERALISED ANXIETY DISORDER, PANIC DISORDER AND OBSESSIVE- COMPULSIVE DISORDER Guideline Title Clinical Investigation of Medical Products
More informationIMMEDIATE AND RESIDUAL EFFECTS IN MAN OF THE METABOLITES OF DIAZEPAM
Br. J. clin. Pharmac. (1978), 6, 2-1 IMMEDIATE AND RESIDUAL EETS IN MAN O THE METABOLITES O DIAZEPAM ORAL H. LARKE & A.N. NIHOLSON Royal Air orce Institute of Aviation Medicine, arnborough, Hampshire I
More informationThe benzodiazepine hangover: Next-day residual effects on driving performance.
The benzodiazepine hangover: Next-day residual effects on driving performance. Stefanie Leung, Faculty of Medicine, The University of Sydney Nicholas Lintzeris, Drug and Alcohol Services, South Eastern
More informationCLOBAZAM AND TRIFLUBAZAM, ON SLEEP IN MAN
Br. J. clin. Pharmac. (1977), 4, 567-572 EFFECT OF THE 1,5-BENZODIAZEPINES, CLOBAZAM AND TRIFLUBAZAM, ON SLEEP IN MAN A.N. NICHOLSON, BARBARA M. STONE & CORAL H. CLARKE Royal Air Force Institute of Aviation
More informationhypnotics and anxiolytics
hypnotics and anxiolytics Hypnotics and anxiolytics Most hypnotics and anxiolytics prescribed in Luxemburg are benzodiazepines and similar medications, such as Z-drugs (see table page 4). Legal status
More informationEFFECTS OF ETHANOL ON PSYCHOMOTOR PERFORMANCE
Br. J. Anaesth. (1987), 59, 961-965 EFFECTS OF ETHANOL ON PSYCHOMOTOR PERFORMANCE D. FAGAN, B. TIPLADY AND D. B. SCOTT Increasingly, psychomotor tests are being used to detect impairment of cerebral function
More informationEffects of Central Nervous System Depressants on Driving
Effects of Central Nervous System Depressants on Driving What is the Drug-Impaired Driving Learning Centre (DIDLC)? The Drug Impaired Driving Learning Centre (DIDLC) is a fully bilingual, web-based educational
More informationSYNOPSIS INTRODUCTION
THE EFFECTS OF THE (SUB)CHRONIC ADMINISTRATION OF AN ANTIHISTAMINE AND MEBHYDROLIN ON REAL CAR DRIVING AND PSYCHOMOTOR PERFORMANCE OF PATIENTS AND HEALTHY VOLUNTEERS * * * * J. J. de Gier, ; J. A. M. Van
More informationHow to prevent iatrogenic risk? benzodiazepine dependence. Aline CORVOL CHU Rennes UMR 6051,
How to prevent iatrogenic risk? benzodiazepine dependence Aline CORVOL CHU Rennes UMR 6051, aline.corvol@chu-rennes.fr CONFLICT OF INTEREST DISCLOSURE I have no potential conflict of interest to report
More informationTRIAZOLAM COMPARED WITH NITRAZEPAM AND WITH
Br. J. clin. Pharmac. (9),, 4S-49S TRIAZOLAM COMPARED WITH NITRAZEPAM AND WITH OXAZEPAM IN INSOMNIA: TWO DOUBLE-BLIND, CROSSOVER STUDIES ANALYZED SEQUENTIALLY G. DORDAIN Clinique Neurologique du Centre
More informationPencil and paper tests- sensitivity to psychotropic drugs
Br. J. clin. Pharmac. (1984), 18, 15S-20S Pencil and paper tests- sensitivity to psychotropic drugs BARBARA M. STONE Royal Air Force Institute of Aviation Medicine, Farnborough, Hampshire 1 The literature
More informationIntroduction. The Netherlands:
MEDICINAL DRUGS AND DRIVING SAFETY: A GRADED-LEVEL SYSTEM FOR LABELING Hilka Wolshrijn, Johan J. De Gier, James F. O'Hanlon (Institute for Drugs, Safety and Behavior - University of Limburg) & Peter A.G.M.
More information1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW)
Dr. Paul A. Farnan farnan@mail.ubc.ca HealthQuest Occupational Health Corporation Alliance Medical Monitoring I have no financial interests or affiliation with any pharmaceutical industry or manufacturer
More informationBenzodiazepines: risks, benefits or dependence
Benzodiazepines: risks, benefits or dependence A re-evaluation Council Report CR 59 January 1997 Royal College of Psychiatrists, London Due for review: January 2002 1 Contents A College Statement 3 Benefits
More informationZopiclone Versus Nitrazepam: A Double-Blind Comparative Study of Efficacy and Tolerance in Elderly Patients with Chronic Insomnia
Sleep lo(suppl. 1):73-78, Raven Press, Ltd., New York 1987 Association of Professional Sleep Societies Zopiclone Versus Nitrazepam: A Double-Blind Comparative Study of Efficacy and Tolerance in Elderly
More informationScreening of Antihistamine Agents (Diphenhydramine) with Blood and Urine Samples by REMEDi-HS System
Screening of Antihistamine Agents (Diphenhydramine) with Blood and Urine Samples by REMEDi-HS System Ohtsuji M, Ohshima T, Takayasu T, Nishigami J, Kondo T, Lin Z, Minamino T Department of Legal Medicine,
More informationCLOBAZAM: PHARMACOLOGICAL AND THERAPEUTIC PROFILE
Br. J. clin. Pharmac. (1979), 7, 151S-155S CLOBAZAM: PHARMACOLOGICAL AND THERAPEUTIC PROFILE G.W. HANKS Medical Department, Hoechst Pharmaceuticals, Hoechst House, Salisbury Road, Hounslow, Middlesex TW4
More informationStrategy in the Use of Biological Markers. in Regranting of Driving Licences
Strategy in the Use of Biological Markers in Regranting of Driving Licences C. M ERCIER-GUYON*, MD,T. ROUPIOZ**, MD, L.GUILLAUM E**, MD *CERMT BP 132 74004 Annecy Cedex **SAMU SAU Centre H ospitalier 74011
More informationAddressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling
Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling Educational Objectives: At the completion of this knowledge-based activity, participants will be able to:
More informationDRINK AND DRUG-RELATED DRIVING
DRINK AND DRUG-RELATED DRIVING Know the dangers We all know that drink driving, and driving while under the influence of drugs, is dangerous. But, even as this behaviour has become increasingly socially
More informationLECTOPAM PRODUCT MONOGRAPH. bromazepam. 3 mg and 6 mg Tablets. Anxiolytic - Sedative. Date of Revision: September 6, 2018
PRODUCT MONOGRAPH LECTOPAM bromazepam 3 mg and 6 mg Tablets Anxiolytic - Sedative Hoffmann-La Roche Limited 7070 Mississauga Road Mississauga, Ontario L5N 5M8 Date of Revision: September 6, 2018 www.rochecanada.com
More informationPERFORMANCE STUDIES WITH ANTIHISTAMINES
Br. J. clin. Pharmnac. (1978), 6,1-5 PERFORMANCE STUDIES WITH ANTIHISTAMINES CORAL H. CLARKE & A.N. NICHOLSON Royal Air Force Institute of Aviation Medicine Farnborough, Hampshire 1 Effect of four antihistamines,
More informationResident Fatigue. A Primer For Residents
Resident Fatigue A Primer For Residents Andrew Martin, MD Chair, Pulmonary Department Deborah Heart and Lung Center Clinical Associate Professor of Medicine MartinA@Deborah.org June 2016 Pre-Test Questions
More informationMedicines and Driver Fitness - Findings from a Metaanalysis of Experimental Studies as Basic Information to Patients, Physicians and Experts
Medicines and Driver Fitness - Findings from a Metaanalysis of Experimental Studies as Basic Information to Patients, Physicians and Experts G Berghaus, B-L Guo Institute of Forensic Medicine, University
More informationPSYCHOTROPIC MEDICATION AND THE WORKPLACE. Dr. Marty Ewer 295 Fullarton Road Parkside
PSYCHOTROPIC MEDICATION AND THE WORKPLACE Dr. Marty Ewer 295 Fullarton Road Parkside 5063 82999281 Introduction Depression and anxiety commonly occur in people who work. The World Health Organization has
More informationBenzodiazepines. Benzodiazepines
: History 1950s - Invented by Swiss chemists who identified its sedative effects 1950s 60s - Chlordiazepoxide (Librium) marketed as a safer alternative to barbiturates; along with newer benzodiazepines
More informationUsing Benzodiazepines in Primary Care
Using Benzodiazepines in Primary Care Spencer A. Tighe MD, FRCPC Saturday, Feb. 16, 2008 Overview Historical context Drug information Indications Side effects Abuse vs. physical dependence Clinical practice
More informationEFFECTS OF BENZODIAZEPINES ON SLEEP AND WAKEFULNESS
Br. J. clin. Pharmac. (1981), 11, 31S-3S EFFECTS OF BENZODIAZEPINES ON SLEEP AND WAKEFULNESS Sleep Disorders and Research Center, Henry Ford Hospital, Detroit, Michigan The differential effects of short
More informationDRIVING, DVLA, AND ADVISING PATIENTS: TOP TIPS
DRIVING, DVLA, AND ADVISING PATIENTS: TOP TIPS DR IÑIGO PEREZ MEDICAL ADVISER, DVLA GENERAL PRACTICE HOT TOPICS NOTTINGHAM 22 APRIL 2017 OUTLINE Drug driving Epilepsy concessions Fit to drive DRUG DRIVING
More informationDIFFERENCE BETWEEN NITRAZEPAM AND LORAZEPAM
DIFFERENCE BETWEEN NITRAZEPAM AND LORAZEPAM Difference Between Nitrazepam And Lorazepam Take is safe and lexapro it to lorazepam With 1mg high lorazepam clozaril dose tablet For boosters lorazepam testosterone
More informationDo non-benzodiazepine-hypnotics prove a valuable alternative to benzodiazepines for the treatment of insomnia?
Do non-benzodiazepine-hypnotics prove a valuable alternative to benzodiazepines for the treatment of insomnia? A. KNUISTINGH NEVEN, DEPARTMENT OF GENERAL PRACTICE, LEIDEN UNIVERSITY MEDICAL CENTER Introduction
More informationa very short half-life, but its main metabolite, which
Br. J. clin. Pharmac. (1979), 8, 3IS-35S BIOAVAILABILITY OF TMAZPAM IN SOFT GLATIN CAPSULS L.M. FUCCLLA Department of Clinical Pharmacology, Carlo rba Research Institute, Milan, Italy 1 Healthy volunteers
More informationDrugs and Alcohol Abuse Policy
Drugs and Alcohol Abuse Policy Introduction From the beginning of 2013, there are increased requirements to provide mandatory proof of inhouse drugs and alcohol testing procedures prior to employees being
More informationPRESCRIBING INFORMATION CHLORDIAZEPOXIDE. Chlordiazepoxide HCl Capsules USP. 5, 10 and 25 mg. Anxiolytic
PRESCRIBING INFORMATION CHLORDIAZEPOXIDE Chlordiazepoxide HCl Capsules USP 5, 10 and 25 mg Anxiolytic AA PHARMA INC. DATE OF PREPARATION: 1165 Creditstone Road Unit #1 June 27, 2012 Vaughan, Ontario L4K
More informationA review of the effects of antihistamines on mental processes related to automobile driving
A review of the effects of antihistamines on mental processes related to automobile driving F. M. Gengo, PharmD, ac and C. Manning a Buffalo, N.Y. The newer, second-generation Hi-receptor antagonists have
More informationWorldwide Trends in Drinking and Driving: Has the Progress Continued?
Worldwide Trends in Drinking and Driving: Has the Progress Continued? B. M. Sweedler Safety and Policy Analysis International, Lafayette, California, USA. Keywords Drinking and Driving, worldwide trends
More informationDrug Review Rozerem (ramelteon)
Drug Review Rozerem (ramelteon) Introduction 1 Ramelteon is a melatonin receptor agonist with affinity for MT 1 and MT 2 and selectivity over the MT 3 receptor. The activity at the MT 1 and MT 2 receptors
More informationauditory flutter fusion threshold (A.F.F.T.), is the auditory equivalent of the visual critical
Br. J. Pharmac. Chemother. (1967), 30, 341-348. THE TIME COURSE OF ACTION OF SINGLE DOSES OF DIAZEPAM, CHLORPROMAZINE AND SOME BARBITURATES AS MEASURED BY AUDITORY FLUTTER FUSION AND VISUAL FLICKER FUSION
More informationGeneral practitioners and hypnotic prescribing: attitudes, perceptions and opportunities to reduce prescribing in primary care
General practitioners and hypnotic prescribing: attitudes, perceptions and opportunities to reduce prescribing in primary care A N Siriwardena, University of Lincoln Tanefa Apekey, Lincolnshire Teaching
More informationcontains the active ingredient diazepam It does not contain all the available information.
VALIUM pronounced (val-i-um) contains the active ingredient diazepam Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about VALIUM. It does not contain all
More informationThe excretion of zopiclone into breast milk
Br. J. clin. Pharmac. (1990), 30, 267-271 The excretion of zopiclone into breast milk I. MATHESON1, H. A. SANDE2 & J. GAILLOT3 'Department of Pharmacotherapeutics, University of Oslo, Oslo, 2Department
More informationSUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS
SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS Guideline Title Summary of Product Characteristics for Benzodiazepines as Anxiolytics or Hypnotics Legislative basis Directive
More informationIt does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.
DUCENE pronounced (dew-seen) contains the active ingredient diazepam Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about DUCENE tablets. It does not contain
More informationAnxiolytic & Hypnotic Drugs. Asst Prof Dr Inam S Arif
Anxiolytic & Hypnotic Drugs Asst Prof Dr Inam S Arif isamalhaj@yahoo.com Anxiolytic & Hpnotic Agents Anxiety: unpleasant state of tension, apprehension or uneasiness, characterised by, tachycardia, sweating,
More informationDriving and Pain. Guidance for Faculty of Pain Medicine Members
Driving and Pain Guidance for Faculty of Pain Medicine Members Introduction Road traffic accidents remain a significant public health problem in the UK. In 2016 there were over 180,000 casualties resulting
More informationThe effects of aircraft noise exposure on subjective sleep quality: the results of the DEBATS study in France
12th ICBEN Congress on Noise as a Public Health Problem The effects of aircraft noise exposure on subjective sleep quality: the results of the DEBATS study in France Ali Mohamed Nassur 1, Marie Lefèvre
More informationTHE ROLE OF ALCOHOL, LICIT AND ILLICIT DRUGS IN TRAFFIC IN EASTERN EUROPE
THE ROLE OF ALCOHOL, LICIT AND ILLICIT DRUGS IN TRAFFIC IN EASTERN EUROPE T. Varga 1, M. Vali 2, R. Wachowiak 3, F. Longauer 4, M. Zorec-Karlovsek 5 1. Dept. of Forensic Medicine, University of Szeged,
More informationMs Anne Dowden. Independent Evaluation Consultant Wellington
Ms Anne Dowden Independent Evaluation Consultant Wellington 16:30-17:25 WS #66: Substance Impaired Driving: Patient Education 17:35-18:30 WS #78: Substance Impaired Driving: Patient Education (Repeated)
More informationMINOR TRANQUILIZERS CHAPTER TWO : MINOR TRANQUILIZERS
MINOR TRANQUILIZERS 76. The term 'minor tranquilizers' was introduced into the scientific literature in the 1950s to distinguish the medicines prescribed to reduce anxiety and tension from the major tranquillizers,
More informationAnxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Anxiolytic, Sedative and Hypnotic Drugs Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anxiolytics: reduce anxiety Sedatives: decrease activity, calming
More informationFriend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines
Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines Program Learning Objectives At the conclusion of the activity, participants should be able to: Have a basic understanding
More informationEffects of Narcotic Analgesics on Driving
Effects of Narcotic Analgesics on Driving What is the Drug-Impaired Driving Learning Centre (DIDLC)? The Drug Impaired Driving Learning Centre (DIDLC) is a fully bilingual, web-based educational resource
More informationThe prescription of psychotropic medication in general practice - a descriptive study
Med. J. Malaysia Vol. 45 No. 3 Sept. 1990 The prescription of psychotropic medication in general practice - a descriptive study T. Maniam, 1 MBBS, MPM Lecturer Ting Shew Ging, MCGP, FRACGP General Practitioner
More informationNOT FOR HUMAN CONSUMPTION
HARMFUL NOT FOR PRESENTATION TO ANYONE UNDER 18 NOT FOR HUMAN CONSUMPTION Benzodiazepines Diazepam Estazolam Etizolam Flunitrazepam Clorazepate Flutoprazepam Phenazepam Tetrazepam Nimetazepam Nordazepam
More informationAbout Your Pain Management
UW MEDICINE PATIENT EDUCATION About Your Pain Management Answers to common questions about opioids This handout explains the goals of managing pain with opioids, which are a type of prescription pain medicine.
More informationA L C O H O L A N D H E A LT H ALCOHOL AND SENIORS
ALCOHOL AND SENIORS TABLE OF CONTENTS Introduction 3 Alcohol and seniors 4 Seniors drinking habits 5 Identifying drinking problems among seniors 7 Abusive and dangerous drinking among seniors 8 Research
More informationMETABOLITES: STUDIES ON SLEEP IN HEALTHY MAN
Br. J. clin. Pharmac. (1979), 8, 57S-61S DIAZEPAM AND ITS HYDROXYLATED METABOLITES: STUDIES ON SLEEP IN HEALTHY MAN Royal Air Force Institute of Aviation Meicine, Farnborough, Hampshire, UK 1 The effects
More informationPersonal development training. Training objectives
STRESS MANAGEMENT Learning about the origins and functions of stress. Studying numerous apprehension techniques in order to manage stress in working conditions and/or in everyday life. What is stress?
More informationEffects of Cannabis on Driving
Effects of Cannabis on Driving What is the Drug-Impaired Driving Learning Centre (DIDLC)? The Drug Impaired Driving Learning Centre (DIDLC) is a fully bilingual, web-based educational resource that was
More informationDo Drowsy Driver Drugs Differ?
University of Iowa Iowa Research Online Driving Assessment Conference 2015 Driving Assessment Conference Jun 25th, 12:00 AM Do Drowsy Driver Drugs Differ? Timothy Brown University of Iowa, Iowa City, IA
More informationYou May Be at Risk. You are taking one of the following sedative-hypnotic medications:
You May Be at Risk You are taking one of the following sedative-hypnotic medications: Alprazolam (Xanax ) Bromazepam (Lectopam ) Chlorazepate Chlordiazepoxideamitriptyline Clidinium-chlordiazepoxide Clobazam
More informationDo You Get Enough Sleep?
LP 3A sleep deprivation 1 Do You Get Enough Sleep? Many college students do not get enough sleep. In a survey of more than 200,000 first year students, more than 80% say that stayed up all night at least
More informationBEHAVIOURAL SCREENING OF DRUGS HYPNOTICS/SEDATIVES
BEHAVIOURAL SCREENING OF DRUGS I. PHARMACOLOGICAL PROPERTIES OF SOME CNS AFFECTIVE AGENTS HYPNOTICS/SEDATIVES The hypnotics and sedatives are one of the most widely prescribed classes of drugs on the market.
More informationRESPONSE TO THE DEPARTMENT FOR TRANSPORT S CONSULTATION PAPER
RESPONSE TO THE DEPARTMENT FOR TRANSPORT S CONSULTATION PAPER REGULATIONS TO SPECIFY THE DRUGS AND CORRESPONDING LIMITS FOR THE NEW OFFENCE OF DRIVING WITH A SPECIFIED CONTROLLED DRUG IN THE BODY ABOVE
More informationYou May Be at Risk. You are currently taking a sedative-hypnotic drug. Please Bring This Information With You To Your Next Medical Appointment
You are currently taking a sedative-hypnotic drug Alprazolam Chlordiazepoxide Clonazepam Diazepam Estazolam Flurazepam Lorazepam Oxazepam Temazepam Triazolam Eszopiclone Zaleplon Zolpidem Please Bring
More informationPROCEDURE REF NO SABP/EXECUTIVE BOARD/0017
PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 NAME OF GUIDELINE REASON FOR GUIDELINE WHAT THE GUIDELINE WILL ACHIEVE? WHO NEEDS TO KNOW ABOUT IT? Medicines Guideline: Hypnotic Medication Compliance with NICE
More informationDRIVING, DVLA, AND ADVISING PATIENTS: TOP TIPS
DRIVING, DVLA, AND ADVISING PATIENTS: TOP TIPS DR IÑIGO PEREZ MEDICAL ADVISER, DVLA GENERAL PRACTICE HOT TOPICS LIVERPOOL 4 FEBRUARY 2017 OUTLINE Case Scenarios Fit to fly X Fit to drive Drug driving Epilepsy
More informationDRUGS THAT ACT IN THE CNS
DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment
More informationFatigue is Too Costly to Ignore: Significance of Clinical Nutrition in Managing Insomnia. The Chiropractic Perspective Mark Kaye, DC
Fatigue is Too Costly to Ignore: Significance of Clinical Nutrition in Managing Insomnia The Chiropractic Perspective Mark Kaye, DC Overview of fatigue and insomnia Up to an estimated 70 million US adults
More informationImpact of mailed feedback on speeding behaviours of convicted male drivers: A brief intervention.
Impact of mailed feedback on speeding behaviours of convicted male drivers: A brief intervention M.C. Ouimet*, T.G. Brown 2, J.-P. Bédard, J. Bergeron Université de Montréal, Canada; 2 McGill University,
More informationReport on Drugged Driving in Louisiana. Quantification of its Impact on Public Health and Implications for Legislation, Enforcement and Prosecution
Report on Drugged Driving in Louisiana Quantification of its Impact on Public Health and Implications for Legislation, Enforcement and Prosecution Objectives Objective 1: Evaluate laws and policies about
More informationAnxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM
Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE NURSING PROGRAM NURS 203 GENERAL PHARMACOLOGY DANITA NARCISO PHARM D Learning Objectives Understand the normal processing of fear vs fear processing
More informationSimultaneous Determination of Prescription and Designer Benzodiazepines in Urine and Blood by SPE and LC-MS/MS
Simultaneous Determination of Prescription and Designer Benzodiazepines in Urine and Blood by SPE and LC-MS/MS UCT Part Numbers CSXCE106 Clean Screen XCEL I 130mg / 6mL SPE Cartridge SPHACE5001-5 Select
More informationLifestyle and Academic Performance Highlights
PA 2007 009 Lifestyle and Academic Performance Highlights Luc Chiasson and Philippe Aubé Cégep de Lévis Lauzon 2008 For more information : Cégep de Lévis Lauzon 205, rue M gr Bourget Lévis (Québec) G6V
More informationLibrium to ativan conversion
11-9-2017 Generalized anxiety disorder (GAD ) is characterized by excessive anxiety and worry that is present more days than not for 6 mo about a number of. benzo.org.uk - Benzodiazepine Equivalence Table.
More informationEvaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites
Evaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites Valérie Thibert 1, Norbert Dirsch 2, Johannes Engl 2, Martin Knirsch 2 1 Thermo Fisher Scientific,
More informationDifference in Blood Alcohol Levels Following Consumption of Whisky and Beer in Man
Difference in Blood Alcohol Levels Following Consumption of Whisky and Beer in Man P. D u ssa u lt1 and C. I. C happel The formulation of many pharmaceutical preparations may influence the absorption of
More informationDRIVING PERFORMANCE OF DRUG-IMPAIRED BUS DRIVERS IN WORK ZONE AREAS
DRIVING PERFORMANCE OF DRUG-IMPAIRED BUS DRIVERS IN WORK ZONE AREAS Chris Deits 1, Linda Ng Boyle 1, & John Morrison 2 1 Department of Industrial and Systems Engineering, University of Washington, Seattle,
More informationANXIETY AND DEPRESSIVE NEUROSIS - THEIR RESPONSE TO ANXIOLYTIC AND ANTIDEPRESSANT TREATMENT GURMEET SINGH 1 R. K. SHARMA 2 SUMMARY
Indian Journal of Psychiatry, January 29(1), pp 49-56 ANXIETY AND DEPRESSIVE NEUROSIS - THEIR RESPONSE TO ANXIOLYTIC AND ANTIDEPRESSANT TREATMENT GURMEET SINGH 1 R. K. SHARMA 2 SUMMARY A total of 90 patients
More informationELLCIE HEALTHY : smart connected eyewear with Artificial Intelligence
PRESS FILE ELLCIE HEALTHY : smart connected eyewear with Artificial Intelligence 09/01/2019 DROWSINESS AND VIGILANCE Falling asleep is one of the major factors of danger on the road as drowsiness at the
More informationAlcohol involvement in pedestrian accidents in France
Alcohol involvement in pedestrian accidents in France Helene FONTAINE and Yves GOURLET INRETS, 94114 Arcueil, Cedex, FRANCE For 25 years the number o f pedestrians killed on the roads has decreased in
More information(Total 2 marks) Name three conditions which are controlled inside our bodies (3)
Q1. Name two drugs which may harm the human body. 1.... 2.... (Total 2 marks) Q2. (a) We control many conditions inside our bodies. Name three conditions which are controlled inside our bodies. 1.... 2....
More informationPATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF ORAL DIAZEPAM TO WORKING AGE AND OLDER PEOPLE IN THE COMMUNITY
PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF ORAL DIAZEPAM TO WORKING AGE AND OLDER PEOPLE IN THE COMMUNITY Version Number: 5 Patient Group Direction drawn up by: Name Ray Lyon Dr Al Amaladoss
More informationUnderstanding Hypnosis
Understanding Hypnosis Are the Results of Hypnosis Permanent? Suggestions stay with some individuals indefinitely, while others need reinforcement. The effects of hypnosis are cumulative: The more the
More informationVersion Number: 5. Patient Group Direction drawn up by: Chief Pharmacist - Strategy. Group direction authorised by:
PATIENT GROUP DIRECTION (PGD) FOR THE INPATIENT ADMINISTRATION OF ORAL LORAZEPAM TO WORKING AGE AND OLDER PEOPLE (includes persons in a Place of Safety suite) Version Number: 5 Patient Group Direction
More informationTHEXANAX THREAT 1 THE XANAX THREAT. iaddiction.com
THEXANAX THREAT 1 THE XANAX THREAT 3 6 9 11 SOCIETAL IMPACT OF XANAX RECREATIONAL VALUE OF XANAX THE PHYSICAL, MENTAL, AND EMOTIONAL EFFECTS OF XANAX ADDICTION AND DEPENDENCE Societal Impact of Xanax Since
More informationDrug Per Se Laws. Key Considerations. The Issue. April Policy Brief
www.ccsa.ca www.ccdus.ca April 2018 Policy Brief Drug Per Se Laws Key Considerations Despite the inherent difficulties associated with establishing per se drug laws, there is sufficient evidence to move
More informationOral Fluid Testing for DUID. Amy Miles Director of Forensic Toxicology UW Madison School of Medicine and Public Health WI State Laboratory of Hygiene
Oral Fluid Testing for DUID Amy Miles Director of Forensic Toxicology UW Madison School of Medicine and Public Health WI State Laboratory of Hygiene Impaired Driving Under-reported statistics Laboratory
More informationClinical Study Synopsis for Public Disclosure
abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis - which is part of the clinical
More informationDYNAMIC INTERACTION OF NOMIFENSINE
Br. J. clin. Pharmac. (1977), 4, 147S-15 1S DYNAMIC INTERACTION OF NOMIFENSINE WITH ALCOHOL K. TAEUBER Medical Department, Hoechst AG, Postfach 8 3 2, D-623 Frankfurt/Main 8 1 Nine healthy volunteers participated
More informationManaging presenting problems with benzodiazepines. By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead
Managing presenting problems with benzodiazepines By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead OUTLINE OF PRESENTATION Why Benzodiazepines (BDZ s) are used Mechanism of Action
More informationCANADIAN TRENDS IN BENZODIAZEPINE & ZOPICLONE USE
CANADIAN TRENDS IN BENZODIAZEPINE & ZOPICLONE USE Aliya Kassam 1, Scott B Patten 2 1 Institute of Psychiatry, London, UK, 2 Department of Community Health Sciences, University of Calgary, Calgary, Alberta,
More informationResidual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study
Psychopharmacology (2014) 231:2785 2798 DOI 10.1007/s00213-014-3447-z ORIGINAL INVESTIGATION Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls:
More informationFit to Drive: A European view on Traffic Safety
Fit to Drive: A European view on Traffic Safety Dr. Don M. DeVol Brussels, 27.06.2018 TOPICS 1. Drunk Driving A European Issue 2. Alcohol-Interlock Programs 3. Overview of European Driver Improvement Measures
More informationANTEROGRADE AMNESIA INDUCED BY THE HYPNOTIC DIAZEPAM IS NOT ASSOCIATED WITH SLEEPINESS
ANTEROGRADE AMNESIA INDUCED BY THE HYPNOTIC DIAZEPAM IS NOT ASSOCIATED WITH SLEEPINESS Agnieszka Unrug l, Marielle Gorissen 2, Gilles van Luijtelaar l, Anton Coenen l 1 NICI, Department of Psychology,
More information